News
 

An article published in the journal Lancet Neurology evaluates the risk of recurrence of active disease in older patients with multiple sclerosis after discontinuing disease-modifying therapies.

Seniors who took low-dose aspirin daily for primary prevention had no reduction in the risk for first strokes in a large randomized trial that followed them for about 5 years (Daily Aspirin Challenged in Primary Stroke Prevention: ASPREE).

Is myocardial infarction (MI) associated with cognition acutely after MI or in the years following MI?

Solanezumab, a monoclonal antibody that binds to the monomeric or soluble form of amyloid-beta, is no better than placebo in slowing the progression of preclinical Alzheimer's disease (AD), results of a phase 3 trial show.

Initiating treatment for multiple sclerosis (MS) within 6 months of the first symptoms is associated with a significantly lower risk for severe disability one decade later, a new study suggests (Neurology. Published online July 19, 2023).

In a new study the authors examined whether cerebrospinal fluid (CSF) baseline levels of the synaptic protein NPTX2 predict time to onset of symptoms of Mild Cognitive Impairment (MCI), both alone and when accounting for traditional CSF Alzheimer's disease (AD) biomarker levels.

A new study demonstrates intensive exercise could decelerate the progression of Parkinson's disease by influencing brain plasticity. The research uncovers a novel mechanism underlying the positive effects of exercise, pinpointing its connection to motor control improvements.

A new study published in PLOS ONE sheds light on how certain anti-inflammatory drugs may prove to be effective treatments for Alzheimer's disease (AD).

Vision impairment in those over 71 could be a potential risk factor for dementia, a new study suggests. By analyzing the National Health and Aging Trends Study (NHATS), the researchers found a notable association between sight loss and the prevalence of dementia among nearly 3,000 US participants.

In a new study published, they investigated the association between childhood diet and developing MS, age of onset and onset type and the association between diet at age 50 and disability and MRI volumes in people with MS (PwMS).